Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (MALS verified), Unconjugated

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (MALS verified), Unconjugated
• Artikelnummer: ABS-SPD-M401A-100UG
• Hersteller Artikelnummer: SPD-M401a-100ug
• Alternativnummer: ABS-SPD-M401A-100UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

The antibody is isolated from the serum of COVID19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARSCoV2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron. - Antikörper

Produkteigenschaften

• Tag: Human IgG3 | Human Kappa
• Puffer: PBS, pH7.4
• Reinheit: 0.95
• Formulierung: Powder
• Target-Kategorie: Spike RBD

Bilder

Immobilized SARS-CoV-2 Spike Trimer, His Tag (B.1.1.529/Omicron) (Cat. No. SPN-C52Hz) at 2µg/mL (100µL/well) can bind Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (Cat. No. SPD-M401a) with a linear range of 0.2-6 ng/mL (QC tested).

Immobilized SARS-CoV-2 Spike protein WT (Cat. No. SPN-C52H9), Alpha (Cat. No. SPN-C52H6), Beta (Cat. No. SPN-C52Hk), Gamma (Cat. No. SPN-C52Hg), Delta (Cat. No. SPN-C52He) and Omicron (Cat. SPN-C52Hz) can bind Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (Cat. No. SPD-M401a) with a linear range of 0.20-6.25 ng/mL (Routinely tested).

Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.